Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20092
20112
20134
20141
20151
20182
20211
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
AstraZeneca2
Bayer2
Novartis Pharmaceuticals2
Advanced Accelerator Applications1
AtheroGenics1
Bracco Diagnostics, Inc1
CSL Behring1
EBI Anti Sepsis BV1
ECRI bv1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease22
Myocardial Infarction5
Atherosclerosis4
Stroke4
Angina Pectoris3
Cardiovascular Diseases3
Heart Diseases3
Peripheral Arterial Disease3
Acute Coronary Syndrome2
Angina, Unstable2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.